Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [21] Pediatric Patient and Caregiver Values in Treatment Decision-making for Uncomplicated Appendicitis
    Apfeld, Jordan C.
    Cooper, Jennifer N.
    Minneci, Peter C.
    Deans, Katherine J.
    JAMA PEDIATRICS, 2021, 175 (01) : 94 - 96
  • [22] Treatment decision making in metastatic prostate cancer (mPC).
    Schumacher, Frank
    Xu, Jiahui
    Oswald, Laura
    Lee, Benjamin
    Gonzalez, Brian
    Zhang, Hui
    Morgans, Alicia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Prostate Cancer Decision-Making, Health Services, and the Family Physician Workforce
    Bowman, Marjorie A.
    Neale, Anne Victoria
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2012, 25 (06) : 753 - 755
  • [24] Treatment experiences and decision-making among patients with metastatic colorectal cancer: Results of an online US patient survey
    Clauer, Julie Saliba
    Ameen, Khadijah
    Incudine, Andrea
    Newcomer, Kimberley Lynn
    Mulvey, Amy
    Steinberg, Kathy
    Geiger, Ashley
    Campbell, Scott
    Calabrese, Ashley V.
    Tejani, Mohamedtaki Abdulaziz
    Shah, Manish A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 80 - 80
  • [25] Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients
    Adsul, Prajakta
    Wray, Ricardo
    Boyd, Danielle
    Weaver, Nancy
    Siddiqui, Sameer
    JOURNAL OF CANCER EDUCATION, 2017, 32 (03) : 580 - 588
  • [26] Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients
    Prajakta Adsul
    Ricardo Wray
    Danielle Boyd
    Nancy Weaver
    Sameer Siddiqui
    Journal of Cancer Education, 2017, 32 : 580 - 588
  • [27] COMMUNICATION BETWEEN THE PATIENT, CAREGIVER AND PHYSICIAN IN TREATMENT DECISION MAKING FOR LOCALIZED PROSTATE CANCER: DEVELOPING A THREE-DIMENSIONAL CODING SYSTEM.
    Bai, Jinbing
    Song, Lixin
    Mishel, Merle
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E230 - E231
  • [28] Impact of Patient Mild Cognitive Impairment on Physician Decision-Making for Treatment
    Blair, Emilie
    Zahuranec, Darin
    Langa, Kenneth M.
    Forman, Jane
    Reale, Bailey K.
    Kollman, Colleen
    Giordani, Bruno
    Levine, Deborah A.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (04) : 1409 - 1417
  • [29] Patient, Physician, and Caregiver Perspectives on Ovarian Cancer Treatment Decision Making: Lessons from a Qualitative Pilot Study
    Pozzar, Rachel
    Baldwin, Laura-Mae
    Goff, Barbara
    Berry, Donna
    NURSING RESEARCH, 2018, 67 (02) : E9 - E9
  • [30] Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: Lessons from a qualitative pilot study
    Pozzar R.
    Baldwin L.-M.
    Goff B.A.
    Berry D.L.
    Pilot and Feasibility Studies, 4 (1)